Literature DB >> 6711809

Use of superoxide dismutase and catalase to protect catecholamines from oxidation in tissue culture studies.

L C Mahan, P A Insel.   

Abstract

A new enzymatic approach for the prevention of catecholamine oxidation that is particularly useful for studies with cultured cells is described. Catecholamine oxidation was assayed by acid alumina chromatography using a modified procedure that yields greater than or equal to 90% column recovery of catecholamine concentrations as low as 1.0 nM. Addition of superoxide dismutase and catalase (10-25 micrograms/ml each) results in virtually complete inhibition of catecholamine oxidation under a variety of experimental conditions. Although superoxide dismutase could prevent catecholamine oxidation, addition of catalase helped prevent the cytotoxicity of oxidative products. When used together, these enzymes have no effect on cell growth, hormonal response, or radioligand binding to membrane beta-adrenergic receptors in the murine S49 lymphoma cell, a widely used model system for studying catecholamine action. Combined use of superoxide dismutase and catalase offers nonperturbing, long-lasting protection of catecholamines in studies with cells in vitro. This method provides a useful alternative to ascorbic acid, chelators, or reducing agents which have previously been used to prevent catecholamine oxidation but which may have other effects on cultured cells and on membrane proteins.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6711809     DOI: 10.1016/0003-2697(84)90327-0

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  8 in total

1.  Activation of p38 mitogen-activated protein kinase by norepinephrine in T-lineage cells.

Authors:  Melissa D Lajevic; Samia Suleiman; Rhonna L Cohen; Donald A Chambers
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

2.  Stimulation of beta-adrenergic receptors of S49 lymphoma cells redistributes the alpha subunit of the stimulatory G protein between cytosol and membranes.

Authors:  L A Ransnäs; P Svoboda; J R Jasper; P A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  In vivo regulation of beta-adrenergic receptors on mononuclear leukocytes and heart. Assessment of receptor compartmentation after agonist infusion and acute aortic constriction in guinea pigs.

Authors:  A S Maisel; M G Ziegler; S Carter; P A Insel; H J Motulsky
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

4.  cAMP stimulates transcription of the beta 2-adrenergic receptor gene in response to short-term agonist exposure.

Authors:  S Collins; M Bouvier; M A Bolanowski; M G Caron; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

5.  Do agonists promote rapid internalization of beta-adrenergic receptors?

Authors:  L C Mahan; H J Motulsky; P A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

6.  Genetic analysis of beta-adrenergic receptor internalization and down-regulation.

Authors:  L C Mahan; A M Koachman; P A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

7.  Beta-adrenoceptor control of immune function in congestive heart failure.

Authors:  A S Maisel; M C Michel
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

8.  Direct relationship between mononuclear leukocyte and lung beta-adrenergic receptors and apparent reciprocal regulation of extravascular, but not intravascular, alpha- and beta-adrenergic receptors by the sympathochromaffin system in humans.

Authors:  S B Liggett; J C Marker; S D Shah; C L Roper; P E Cryer
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.